• JUNE 22, 2017
    • 0

    ASCO UPDATE 2017

    Tuesday evening Barry H. Kaplan, M.D. Ph.D. delivered by most attendee’s accounts his best rendition of his the 30-plus annual syntheses of the Annual American Society of Clinical Oncology (ASCO) meeting, called the ASCO Update. Malvina Fulman, MD, fellow hematologist-oncologist and practice partner, introduced Dr Kaplan as “the best speaker in her experience”. In his

    Read more
    • JULY 31, 2015
    • 0

    Clinical Trials Should Have A Category For The Elderly

    QMA physicians keep the patient’s individual situation in mind when prescribing chemotherapy or immune-therapy. Certain calculations are part of prescribing an effective dose of medication – the patient’s total surface area, age, and general health. These considerations help patients tolerate treatment with fewer side effects. Clinical trials do not typically account for these factors when

    Read more